- Home
- DNTH vs TXO Comparison
DNTH vs TXO Comparison
Compare DNTH & TXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNTH | TXO |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 781.2M |
| IPO Year | 2018 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DNTH | TXO |
|---|---|---|
| Price | $105.83 | $15.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $121.00 | $20.50 |
| AVG Volume (30 Days) | ★ 544.6K | 188.1K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,036,000.00 | ★ $401,012,000.00 |
| Revenue This Year | N/A | $17.21 |
| Revenue Next Year | $29.48 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 41.80 |
| 52 Week Low | $32.28 | $10.12 |
| 52 Week High | $117.88 | $15.44 |
Technical Indicators
Market Signals| Indicator | DNTH | TXO |
|---|---|---|
| Relative Strength Index (RSI) | 46.07 | 66.38 |
| Support Level | $101.19 | $12.21 |
| Resistance Level | $107.99 | N/A |
| Average True Range (ATR) | 4.59 | 0.40 |
| MACD | -0.78 | 0.06 |
| Stochastic Oscillator | 34.42 | 86.06 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
About TXO TXO Partners L.P.
TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America. Its operations focus on enhancing the development and operation of producing properties through its concentration on efficiency and optimizing exploitation of current wells.